Document is current
Any future updates will be listed below
-
Authors
Roberts, Kevin J.
Cubitt, Marion F.
Carlton, Timothy M.
Rodrigues-Duarte, Lurdes
Maggiore, Luana
Chai, Ray
Clare, Simon
Harcourt, Katherine
MacDonald, Thomas T.
Ray, Keith P.
Vossenkämper, Anna
West, Michael R.
Crowe, J. Scott
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
Janssen Pharmaceuticals
VHsquared
Grunenthal
Pfizer
Kymab
Topivert
Celgene
- License Information
-
More Information
Article History
Received: 24 May 2021
Accepted: 10 August 2021
First Online: 30 September 2021
Competing interests
: J.S.C., K.J.R., T.M.C., L.M., M.F.C., K.P.R., L.D., R.C. and M.R.W. were employees of VHsquared. A.V. received research funding from VHsquared. S.C. and K.H. disclose no conflicts. T.T.M. received honoraria and/or research funding from Janssen, G.S.K., VHsquared, Grunenthal, Pfizer, Kymab, Topivert and Celgene.
